Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of nucleolin as a biomarker for lymphangiogenesis in a cancer prognosis and therapy

Use of nucleolin as a biomarker for lymphangiogenesis in a cancer prognosis and therapy

US Patent 10054590 · Granted Aug 21, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Interface display method and apparatus, and storage medium2023
Delay-line based transceiver calibration2023
High gain-bandwidth product (GBW) amplifier with passive feedforward compensatio2023
Nucleolin-mediated cancer diagnostics and therapy2022
Pegylated endostatin analogue and application thereof2021
Molecular design of recombinant protein drug2020
Transmitter using hybrid beamforming and performing a code division feedback met2020
Endostatin mutants with mutations at ATP binding sites2020
Endostatin mutants with mutations at ATP binding sites2020
Endostatin mutants with mutations at ATP binding sites2020
Filter circuit2020
Process for the preparation of spiro[2.5]octane-5,7-dione and spiro[3.5]nonane-62018